NGM · Financial Statements

Fractyl Health, Inc. (GUTS) Financial Statements

$1.08 NGM: GUTS Market Cap $14.33M

Fractyl Health, Inc. most recently reported annual revenue of $0, a net loss of $141.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Fractyl Health, Inc.: net profit was positive in 0 of 7 reported years; operating margin moved from -42363.3% to -100571.0%, a shift of -58207.6 percentage points; the most recent year shows a net loss of $141.0M.

Income Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Revenue$0$0$0$0$0$0$0
Operating Expenses$30.0M$29.0M$37.0M$49.0M$51.0M$94.0M$97.0M
Operating Profit$-30.0M$-29.0M$-37.0M$-49.0M$-51.0M$-94.0M$-97.0M
Operating Margin0.0%0.0%0.0%0.0%-42363.3%-100571.0%0.0%
Other Income$-1.0M$-2.0M$-2.0M$3.0M$-26.0M$25.0M$-44.0M
Interest$1.0M$2.0M$1.0M$0$0$0$0
Depreciation$1.0M$1.0M$1.0M$0$0$1.0M$1.0M
Profit Before Tax$-31.0M$-30.0M$-39.0M$-46.0M$-77.0M$-69.0M$-141.0M
Tax$0$0$0$0$0$0$0
Net Profit$-31.0M$-30.0M$-39.0M$-46.0M$-77.0M$-69.0M$-141.0M
EPS$-7.68$-10.32$-13.44$-16.08$-23.76$-19.44$-11.04
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Operating Expenses$14.0M$13.0M$22.0M$23.0M$24.0M$25.0M$25.0M$26.0M$23.0M$23.0M$21.0M$19.0M
Operating Profit$-14.0M$-13.0M$-22.0M$-23.0M$-24.0M$-25.0M$-25.0M$-26.0M$-23.0M$-23.0M$-21.0M$-19.0M
Operating Margin-38536.1%-185442.9%-65278.8%-53453.5%-169957.1%-840333.3%0.0%0.0%0.0%0.0%0.0%0.0%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-16.0M$-19.0M$-3.0M$-17.0M$-23.0M$-25.0M$-24.0M$-28.0M$-46.0M$-44.0M$9.0M$-26.0M
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$-16.0M$-19.0M$-3.0M$-17.0M$-23.0M$-25.0M$-24.0M$-28.0M$-46.0M$-44.0M$9.0M$-26.0M
EPS$-0.42$-0.40$-0.11$-0.36$-0.48$-0.51$-0.49$-0.56$-0.71$-0.29$0.06$-0.16

Over the 7 years reported for Fractyl Health, Inc., borrowings increased from $15.0M in 2019 to $62.0M in 2025, cash stood at $82.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 4.89 times.

Balance Sheet — 7 Years (USD millions)

Metric2019202020212022202320242025
Total Assets$9.0M$35.0M$103.0M$61.0M$76.0M$108.0M$121.0M
Current Assets$7.0M$31.0M$96.0M$52.0M$36.0M$72.0M$88.0M
Cash$6.0M$29.0M$95.0M$49.0M$34.0M$67.0M$82.0M
Inventory$0$0$0$0$0$0$0
Receivables$0$0$0$0$0$0$0
Fixed Assets$2.0M$1.0M$1.0M$2.0M$31.0M$31.0M$29.0M
Capital Work in Progress$0$0$0$0$0$0$0
Investments$0$0$0$4.0M$4.0M$4.0M$4.0M
Other Assets$0$0$0$0$0$0$0
Total Liabilities$153.0M$20.0M$312.0M$313.0M$401.0M$80.0M$112.0M
Current Liabilities$3.0M$11.0M$24.0M$7.0M$11.0M$20.0M$18.0M
Borrowings$15.0M$15.0M$304.0M$307.0M$374.0M$63.0M$62.0M
Other Liabilities$138.0M$5.0M$8.0M$6.0M$28.0M$17.0M$50.0M
Equity$21.0M$0$0$0$0$0$0
Reserves$-144.0M$15.0M$-209.0M$-252.0M$-325.0M$28.0M$9.0M

For Fractyl Health, Inc., operating cash flow was positive in 0 of 7 reported years; free cash flow in the latest year was negative at $91.0M; free cash flow was positive in 0 of 7 years.

Cash Flow Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Operating Cash Flow$-28.0M$-31.0M$-33.0M$-46.0M$-43.0M$-66.0M$-90.0M
Investing Cash Flow$0$0$0$0$-1.0M$-4.0M$-1.0M
Financing Cash Flow$0$0$0$0$-1.0M$-2.0M$0
Net Cash Flow$-13.0M$23.0M$66.0M$-46.0M$-16.0M$34.0M$14.0M
Free Cash Flow$-28.0M$-31.0M$-34.0M$-46.0M$-43.0M$-67.0M$-91.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.28
FCF Yield-540.42%
Quick Ratio3.15
Interest Coverage—
Return 1Y-35.15%
Return 3Y—
Return 5Y—

Fractyl Health, Inc. (GUTS) financials — frequently asked questions

What is Fractyl Health, Inc.'s annual revenue?

Fractyl Health, Inc. (GUTS) reported annual revenue of $0 in its most recent fiscal year.

What is Fractyl Health, Inc.'s net profit?

Fractyl Health, Inc. (GUTS) reported a net loss of $141.0M in its most recent fiscal year.

What is GUTS EV/EBITDA?

Fractyl Health, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.28. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
GUTS Overview GUTS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.